Invention Grant
US09296692B2 Use of indolyl and indolinyl hydroxamates for treating heart failure of neuronal injury
有权
吲哚基和二氢吲哚基异肟酸盐用于治疗神经元损伤的心力衰竭
- Patent Title: Use of indolyl and indolinyl hydroxamates for treating heart failure of neuronal injury
- Patent Title (中): 吲哚基和二氢吲哚基异肟酸盐用于治疗神经元损伤的心力衰竭
-
Application No.: US14345246Application Date: 2012-09-15
-
Publication No.: US09296692B2Publication Date: 2016-03-29
- Inventor: Yi-Jen Chen , Kuo-Sheng Hung , Yu-Hsun Kao , Jing-Ping Liou , Pei-Wen Shan
- Applicant: Yi-Jen Chen , Kuo-Sheng Hung , Yu-Hsun Kao , Jing-Ping Liou , Pei-Wen Shan
- Applicant Address: TW Taipei
- Assignee: TAIPEI MEDICAL UNIVERSITY
- Current Assignee: TAIPEI MEDICAL UNIVERSITY
- Current Assignee Address: TW Taipei
- Agency: McClure, Qualey & Rodack, LLP
- International Application: PCT/US2012/055664 WO 20120915
- International Announcement: WO2013/040520 WO 20130321
- Main IPC: C07D209/30
- IPC: C07D209/30 ; C07D209/08 ; C07D209/18 ; A61K31/404
Abstract:
Novel use of small molecules, particularly indolyl and indolinyl hydroxamates is disclosed herein. The indolyl and indolinyl hydroxamates are useful as lead compounds for manufacturing a medicament or a pharmaceutical composition for treating a patient suffering from heart failure or neuronal injury.
Public/Granted literature
- US20150065552A1 Use of Indolyl and Indolinyl Hydroxamates for Treating Heart Failure of Neuronal Injury Public/Granted day:2015-03-05
Information query
